NovaBridge Biosciences Operating Lease, Payments
NovaBridge Biosciences (NBP) reported Operating Lease, Payments of $1.01 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-04-07
- NovaBridge Biosciences operating lease, payments for the quarter ending 2020-12-31 was 1.90M CNY, a 55.65% increase year-over-year.
- NovaBridge Biosciences operating lease, payments for the quarter ending 2019-12-31 was 1.22M CNY.
CNY
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2023-12-31 | 22.09M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 35.71M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 17.36M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 18.67M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | 6.82M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 1.90M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 8.84M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 6.93M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 1.22M CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 6.17M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 4.95M CNY 6-K · filed 2021-02-05 |
USD
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $253.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $506.00K derived: sum of 2 quarters · filed 2026-04-07 | $1.01M 20-F · filed 2026-04-07 | ||
| 2025-09-30 | $253.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $758.00K 6-K · filed 2025-12-18 | |||
| 2025-06-30 | $505.00K 6-K · filed 2025-10-06 | ||||
| 2024-12-31 | $236.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $466.00K derived: sum of 2 quarters · filed 2026-04-07 | $805.00K 20-F · filed 2026-04-07 | ||
| 2024-09-30 | $230.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $569.00K 6-K · filed 2025-12-18 | |||
| 2024-06-30 | $339.00K 6-K · filed 2025-10-06 | ||||
| 2023-12-31 | $739.00K 20-F · filed 2026-04-07 | $3.11M 20-F · filed 2024-04-30 | |||
| 2022-12-31 | $909.00K 20-F · filed 2025-04-03 | $5.18M 20-F · filed 2023-05-01 | |||
| 2022-06-30 | $2.59M 6-K · filed 2022-11-10 | ||||
| 2021-12-31 | $2.93M 20-F · filed 2022-04-29 | ||||
| 2020-12-31 | $333.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $1.35M 20-F · filed 2021-04-28 | |||
| 2020-09-30 | $1.02M 6-K · filed 2021-02-05 | ||||
| 2019-12-31 | $887.00K 20-F · filed 2020-04-29 |